Syngenis banks $4M pre-float to power AI-driven biotech platform

🇦🇺 The Sydney Morning Herald (AU) —
Syngenis banks $4M pre-float to power AI-driven biotech platform

AI Summary

Perth-based biotech company Syngenis Labs raised an oversubscribed $4 million pre-IPO funding round to expand its AI-driven RNA platform and enhance genetic medicine capabilities in Australia.

Perth biotech Syngenis Labs has banked an oversubscribed $4M pre-IPO raise to expand its AI-powered RNA platform and strengthen domestic genetic medicine capability.

Markets Deals Health AI & Tech biotech AI platform RNA funding pre-IPO genetic medicine Australia

Read original source →